Research programme: indole-3-carbinol derivatives - EurandAlternative Names: Indole-3-carbinol derivatives research programme - Eurand/University of Urbino
Latest Information Update: 13 Apr 2010
At a glance
- Originator Eurand; University of Urbino
- Mechanism of Action Protein kinase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 04 May 2007 No development reported - Preclinical for Cancer in Italy (unspecified route)
- 21 Apr 2004 Preclinical trials in Cancer in Italy (unspecified route)